Exchange: NASDAQ·Updated 04:00 PM EDT

ATTO Attovia Therapeutics Inc.

$13.89
$0.16
(1.17%)
Today
EarningsNov 11
Mkt Cap$626.79M
Vol297,538.00

About ATTO

Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
47

Neutral Sentiment

How do you feel about ATTO?

Advertisement|Remove ads.